This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_URINARY_TRACT_NAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified urinary organs
C3_URINARY_TRACT_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
94 |
4. Check minimum number of eventsNone |
94 |
5. Include endpointsNone |
94 |
6. Filter based on genotype QC (FinnGen only) |
94 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified urinary organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 94 | 27 | 67 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 73.66 | 70.71 | 74.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UKC02
NOMESCO Finland
Cystoscopy
26.0
39.0
79
165
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
47.7
36.4
44
17
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
33.3
30
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
31.1
28.3
38
20
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
159.5
23.8
24
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
75.2
21.0
23
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
20.6
19
*
KAC20
NOMESCO Finland
Nephroureterectomy
125.8
19.4
20
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
56.6
19.2
22
5
UKB02
NOMESCO Finland
Retrograde ureteroscopy
42.9
19.0
23
7
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
30.4
19.0
25
11
R31
ICD-10 Finland
Unspecified haematuria
8.2
18.0
49
111
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
62.8
17.8
20
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
205.3
17.1
17
*
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
16.1
15
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
15.0
14
*
ZX136
NOMESCO Finland
Intravesicalis
54.3
12.3
14
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.1
12.0
37
90
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
49.8
11.2
13
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
25.1
11.1
15
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.8
10.9
20
21
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
14.6
10.9
18
15
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
10.6
10
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
19.5
10.3
15
9
KCC10
NOMESCO Finland
Cystoprostatectomy
45.3
10.2
12
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
61.6
9.9
11
*
130
Kela drug reimbursment
Malignant tumour
6.2
9.8
28
60
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.5
9.8
20
26
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
20.3
9.7
14
8
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
+∞
9.5
9
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
13.5
9.5
16
14
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
9.3
43
156
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
55.4
8.9
10
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
30.8
8.7
11
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
98.6
8.6
9
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.5
8
*
J01MA02
ATC
ciprofloxacin; systemic
3.6
7.9
57
285
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
13.5
7.9
13
11
J01EA01
ATC
trimethoprim; systemic
3.7
7.7
40
156
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
7.4
7
*
J01MA12
ATC
levofloxacin; systemic
3.6
7.0
36
137
TJF80
NOMESCO Finland
Ostomy education
24.6
6.8
9
*
H02AB02
ATC
dexamethasone; systemic
5.0
6.8
22
54
B01AB10
ATC
tinzaparin; parenteral
5.7
6.7
19
40
R33
ICD-10 Finland
Retention of urine
4.5
6.6
24
67
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
74.8
6.5
7
*
J01CA08
ATC
pivmecillinam; oral
3.4
6.5
37
151
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
19.7
6.4
9
5
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
6.3
6
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
6.3
6
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.7
6.3
30
107
JN4CD
NOMESCO Finland
Very extensive body CT
6.2
6.2
16
30
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
294
3.38
7.71
7.4
3.3
—
—
—
0
0
59
311
3.41
7.70
5.9
4.3
—
—
—
0
0
34
158
2.80
5.09
2.8
2.2
—
—
—
0
0
20
72
3.26
4.63
9.4
4.1
6.0
5.5
kpa
1.35
20
67
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
32
4.15
4.23
4.2
2.0
0.3
0.4
u/ml
—
6
17
25
119
2.50
3.44
2.2
1.7
30.0
29.8
s
0.08
25
114
24
130
2.14
2.41
8.4
3.2
2.5
2.1
e6/l
0.09
16
83
48
334
1.89
2.38
6.5
4.0
0.0
0.0
estimate
0.00
16
74
51
364
1.88
2.32
15.5
5.7
1.2
1.2
mmol/l
0.44
41
300
8
24
3.54
2.23
2.4
2.0
—
—
—
0
0
23
127
2.07
2.19
8.2
2.9
4.3
1.2
e6/l
0.37
15
79
11
45
2.64
2.01
1.5
1.3
—
—
—
0
0
47
339
1.77
1.97
8.7
5.5
0.0
0.0
estimate
0.00
15
68
50
369
1.76
1.92
14.8
8.1
4.6
4.5
e9/l
0.12
45
318
46
333
1.75
1.88
7.7
3.9
31.7
34.4
g/l
2.71
41
309
47
343
1.74
1.86
6.5
4.1
0.0
0.0
estimate
0.00
16
66
5
12
4.33
1.84
1.2
1.3
—
—
—
0
0
18
103
1.92
1.54
16.3
5.4
-1.5
1.3
mmol/l
1.33
12
85
28
196
1.61
1.22
7.0
4.1
0.0
0.0
estimate
0.00
11
66
0
33
0.00
1.19
0.0
1.6
—
1.9
—
0
23
10
52
2.03
1.11
3.1
3.8
0.3
0.2
e6/l
—
10
52
10
53
1.99
1.06
1.9
3.0
32.4
55.5
ml/min/173m2
—
5
20
10
53
1.99
1.06
6.8
1.8
556.8
371.8
nmol/l
—
10
48
11
62
1.88
0.99
2.4
1.4
—
—
—
0
0
34
262
1.47
0.94
7.9
4.4
—
—
—
0
0
11
173
0.59
0.86
1.8
1.7
1.2
1.2
mmol/l
0.01
11
141
22
158
1.51
0.85
2.7
2.7
2.5
2.5
mmol/l
0.25
17
138
13
84
1.64
0.76
7.3
4.1
—
—
—
0
0
0
21
0.00
0.61
0.0
1.2
—
—
—
0
0
26
207
1.35
0.58
2.7
2.0
3.3
3.0
mg/l
0.40
20
181
33
278
1.29
0.50
2.1
2.1
—
—
—
0
0
72
671
1.31
0.47
40.1
21.0
127.9
87.3
umol/l
3.22
72
671
5
31
1.65
0.44
1.4
1.9
—
—
—
0
0
12
89
1.40
0.40
2.0
1.8
—
—
—
0
0
5
35
1.45
0.40
1.0
1.3
2.6
3.2
g/l
—
5
28
12
92
1.35
0.34
1.7
1.8
—
—
—
0
0
36
321
1.20
0.31
2.0
2.1
95.1
89.8
pmol/l
0.30
23
168
16
132
1.26
0.28
1.9
1.8
—
—
—
0
0
41
446
0.86
0.26
4.4
3.6
15.0
14.9
pmol/l
0.03
35
384
5
38
1.33
0.23
1.0
1.3
11.8
10.4
g/l
—
5
33
5
40
1.26
0.23
1.0
1.3
4.4
4.0
g/l
—
5
27
5
40
1.26
0.23
1.0
1.3
—
—
—
0
0
5
40
1.26
0.23
1.6
1.2
—
—
—
0
0
5
40
1.26
0.23
1.0
1.3
6.8
8.0
g/l
—
5
29
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
6
52
1.16
0.19
4.8
4.7
22.7
24.8
mmol/l
—
6
52
55
577
0.89
0.18
4.6
4.5
2.0
2.2
mu/l
0.48
45
493
65
627
1.12
0.15
4.9
5.5
6.0
6.1
mmol/l
0.44
55
558
5
48
1.04
0.09
1.4
1.6
—
—
—
0
0
59
606
0.93
0.08
6.8
7.1
41.7
42.2
mmol/mol
0.16
53
549
39
374
1.07
0.08
4.2
5.5
7.6
2.3
ug/l
0.53
30
325
20
213
0.92
0.07
2.9
3.1
0.8
0.8
ug/l
0.02
14
155
64
631
1.04
0.03
4.3
5.8
2.3
2.4
mmol/l
0.46
58
561
58
588
0.96
0.02
4.1
4.5
1.2
1.2
mmol/l
0.02
53
516
61
612
0.99
0.00
4.2
5.1
4.1
4.3
mmol/l
0.35
56
546
61
608
1.01
0.00
4.0
5.0
1.4
1.4
mmol/l
0.14
56
534
30
299
1.00
0.00
3.4
4.6
20.8
21.7
%
0.12
18
158
33
333
0.99
0.00
6.2
4.1
56.4
59.5
ng/l
0.05
28
267
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
6
69
0.86
0.00
2.7
2.3
23.7
33.6
u/l
—
6
56
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
9
89
1.01
0.00
18.0
8.5
—
—
—
0
0
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
13.3
—
0
9
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
6.0
—
200.0
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
6
59
1.02
0.00
1.5
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
13.9
—
0
5
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1.5
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URINARY_TRACT_NAS – Malignant neoplasm of other and unspecified urinary organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).